Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@gcfmd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1035490068.png) @gcfmd Gregg Fonarow MD

Gregg Fonarow MD posts on X about  the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1035490068/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1035490068/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXXX +209%
- X Months XXXXXX +155%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::1035490068/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1035490068/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month X +14%
- X Months XX +67%
- X Year XX -XX%

### Followers: XXXXXX [#](/creator/twitter::1035490068/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1035490068/c:line/m:followers.svg)

- X Week XXXXXX +0.03%
- X Month XXXXXX +0.84%
- X Months XXXXXX +3.60%
- X Year XXXXXX +5.40%

### CreatorRank: undefined [#](/creator/twitter::1035490068/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1035490068/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1035490068/influence)
---

**Social category influence**
[stocks](/list/stocks) 
### Top Social Posts [#](/creator/twitter::1035490068/posts)
---
Top posts by engagements in the last XX hours

"Amgen announced the Phase X VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that evolocumab significantly reduced the risk of MACE in individuals without a prior history of heart attack or stroke 12000 high-risk patients median of XXX years @kewatson"  
[X Link](https://x.com/gcfmd/status/1973913387513135504) [@gcfmd](/creator/x/gcfmd) 2025-10-03T00:49Z 11.9K followers, 1853 engagements


"direct-to-consumer evolocumab (Repatha) to be available at a discounted cash price of $XXX a month Amgen to sell cholesterol drug at XX% discount to cash-paying US patients @kewatson @boback @pnatarajanmd @kardiologykazi"  
[X Link](https://x.com/gcfmd/status/1975535280250929534) [@gcfmd](/creator/x/gcfmd) 2025-10-07T12:14Z 11.9K followers, 2861 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@gcfmd Avatar @gcfmd Gregg Fonarow MD

Gregg Fonarow MD posts on X about the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXXX +209%
  • X Months XXXXXX +155%
  • X Year XXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Week X -XX%
  • X Month X +14%
  • X Months XX +67%
  • X Year XX -XX%

Followers: XXXXXX #

Followers Line Chart

  • X Week XXXXXX +0.03%
  • X Month XXXXXX +0.84%
  • X Months XXXXXX +3.60%
  • X Year XXXXXX +5.40%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #

Social category influence stocks

Top Social Posts #

Top posts by engagements in the last XX hours

"Amgen announced the Phase X VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that evolocumab significantly reduced the risk of MACE in individuals without a prior history of heart attack or stroke 12000 high-risk patients median of XXX years @kewatson"
X Link @gcfmd 2025-10-03T00:49Z 11.9K followers, 1853 engagements

"direct-to-consumer evolocumab (Repatha) to be available at a discounted cash price of $XXX a month Amgen to sell cholesterol drug at XX% discount to cash-paying US patients @kewatson @boback @pnatarajanmd @kardiologykazi"
X Link @gcfmd 2025-10-07T12:14Z 11.9K followers, 2861 engagements

@gcfmd
/creator/twitter::gcfmd